Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent announced the appointment of Sridhar Krishnan, to the newly created position of Vice President, The Catalent Way.
read more
Tuesday, December 01, 2020
Catalent announced the appointment of Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy.
read more
Catalent has signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) technology platform.
read more
Catalent Pharma Solutions and Berkeley Lights announced Catalent Biologics will adopt BLI’s Beacon optofluidic platform to accelerate its cell line development workflow.
read more
Thursday, January 22, 2015
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Mitsubishi Gas Chemical Company, Inc. (MGC), today jointly announced that they ...
read more
Catalent Pharma Solutions announced Graham Brearley, Ph.D., has been appointed as General Manager of the company’s Madison, Wisconsin facility.
read more
Wednesday, August 05, 2015
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has formed an advisory board to strategically shape growth of the company’s biologics business.
read more
Wednesday, January 13, 2016
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products has announced, through its wholly owned subsidiary, Redwood Bioscience, Inc., a research collaboration with Roche...
read more
Monday, December 19, 2016
Catalent Pharma Solutions has signed an agreement with PATH, an international nonprofit organization and a leader in global health innovation, to advance a project funded by its Malaria Vaccine Initiative (MVI).
read more
Catalent announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility.
read more
Catalent announced today that it has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, Wisconsin.
read more
Friday, November 20, 2015
Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics. These investments include a significant expansion of bioassay and protein characterization capabilities at its ...
read more
Thursday, September 03, 2020
Catalent announced it is investing $50 million to install an additional high-speed vial filling line at its Bloomington, Indiana, facility.
read more
Wednesday, November 06, 2019
Catalent announced the launch of its cell line development technology, GPEx® Boost.
read more
Catalent announced the launch of a next-generation cell line development technology, GPEx® Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx ...
read more